Items where Author is "Ramanathan, S."

Article

(2026) Causal effects of multiple sclerosis therapies in left-truncated registry data. Multiple sclerosis (Houndmills, Basingstoke, England). pp. 1052-1068. ISSN 1477-0970 (Electronic) 1352-4585 (Print) 1352-4585 (Linking)

(2026) Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry. Journal of Neurology. p. 15. ISSN 0340-5354

(2026) Predicting disease progression in multiple sclerosis with clinically accessible information and technology. Journal of Neurology. p. 18. ISSN 0340-5354

(2025) Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum. Genetics in Medicine. p. 23. ISSN 1098-3600

(2025) Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA neurology. ISSN 2168-6157 (Electronic) 2168-6149 (Print) 2168-6149 (Linking)

(2024) Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders. medRxiv : the preprint server for health sciences.

(2024) A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. Journal of Neurology. p. 12. ISSN 0340-5354

(2024) A standardised definition of progression independent of relapse activity in multiple sclerosis. Multiple Sclerosis Journal. pp. 442-445. ISSN 1352-4585